Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/EIGER-BIOPHARMACEUTICALS--26727607/news/Eiger-BioPharmaceuticals-to-Host-Conference-Call-to-Discuss-Phase-3-D-LIVR-Study-Results-of-Lonafarn-42506167/?utm_source=whatsapp&utm_medium=social&utm_campaign=share